New cancer pill shows promise in early trial
Disease control
Completed
This early-phase trial tested a new oral drug called ART4215 in 93 people with advanced or metastatic solid tumors, including breast cancer. The main goals were to find a safe dose and check for side effects when given alone or with other cancer drugs (talazoparib or niraparib). …
Phase: PHASE1 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC